Dennis Reilly insider trades: Agile Therapeutics (AGRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dennis reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | AGRX | ↑ Buy | 50,000 | $1.08 | $54K | Direct | Jul 28, 2021 (1d) |
| May 11, 2021 | AGRX | ↑ Buy | 20,000 | $1.35 | $27K | Direct | May 12, 2021 (1d) |
| Mar 23, 2021 | AGRX | ↑ Buy | 50,000 | $2.05 | $102K | Direct | Mar 23, 2021 (0d) |
| Sep 28, 2020 | AGRX | ↑ Buy | 9,000 | $2.85 | $26K | Direct | Sep 28, 2020 (0d) |
| Mar 4, 2020 | AGRX | ↑ Buy | 50,000 | $2.32 | $116K | Direct | Mar 6, 2020 (2d) |
| Mar 4, 2020 | AGRX | ↑ Buy | 25,000 | $2.35 | $59K | By Spouse. | Mar 6, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Dennis Reilly's insider trades
Dennis Reilly is Chief Financial Officer at Agile Therapeutics (AGRX). Since Mar 4, 2020, Dennis has reported 6 open-market purchases worth $384K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), other transactions (2 filings), option exercises (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.